Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tamique Mason"'
Autor:
Kim A. Connelly, C. David Mazer, Pankaj Puar, Hwee Teoh, Chao-Hung Wang, Tamique Mason, Farhad Akhavein, Ching-Wen Chang, Min-Hui Liu, Ning-I Yang, Wei-Siang Chen, Yu-Hsiang Juan, Erika Opingari, Yaseen Salyani, William Barbour, Aryan Pasricha, Shamon Ahmed, Andrew Kosmopoulos, Raj Verma, Michael Moroney, Ehab Bakbak, Aishwarya Krishnaraj, Deepak L. Bhatt, Javed Butler, Mikhail N. Kosiborod, Carolyn S.P. Lam, David A. Hess, Otavio Rizzi Coelho-Filho, Myriam Lafreniere-Roula, Kevin E. Thorpe, Adrian Quan, Lawrence A. Leiter, Andrew T. Yan, Subodh Verma
Publikováno v:
Circulation. 147:284-295
Background: Sodium-glucose cotransporter 2 inhibitors have been demonstrated to promote reverse cardiac remodeling in people with diabetes or heart failure. Although it has been theorized that sodium-glucose cotransporter 2 inhibitors might afford si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6028a667869cc851e4a986d17963d3f8
https://doi.org/10.1161/circulationaha.122.062769
https://doi.org/10.1161/circulationaha.122.062769
Autor:
Adrian Quan, David Fitchett, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Shaun G. Goodman, Mohammed Al-Omran, Ronald Goldenberg, Vinay Garg, Tamique Mason, Peter Jüni, Andrew T. Yan, Deepak L. Bhatt, Hwee Teoh, C. David Mazer, Richard E. Gilbert, Subodh Verma, Michael E. Farkouh, Kim A. Connelly
Publikováno v:
Circulation. 140:1693-1702
Background: SGLT2 (sodium-glucose cotransporter 2) inhibitors lower cardiovascular events in type 2 diabetes mellitus but whether they promote direct cardiac effects remains unknown. We sought to determine if empagliflozin causes a decrease in left v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323888abb78cdba2dcb17f441601f9c3
https://doi.org/10.1161/circulationaha.119.042375
https://doi.org/10.1161/circulationaha.119.042375
Autor:
Peter Jüni, Kevin E. Thorpe, Christopher Bonneau, Hwee Teoh, C. David Mazer, Tamique Mason, Bernard Zinman, Kim A. Connelly, Biswajit Chowdhury, Subodh Verma, Lawrence A. Leiter, Michael Jerosch-Herold, Adrian Quan, Otavio R. Coelho-Filho, Andrew T. Yan, Fei Zuo, Richard E. Gilbert
Publikováno v:
JACC. Cardiovascular imaging. 14(6)
Objectives This study sought to evaluate the effects of empagliflozin on extracellular volume (ECV) in individuals with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). Background Empagliflozin has been shown to reduce left ventricu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9feaff853577c5b3f78a36f1656ce0d4
https://pubmed.ncbi.nlm.nih.gov/33454271
https://pubmed.ncbi.nlm.nih.gov/33454271
Autor:
Justin Z. Trac, Ori D. Rotstein, Tamique Mason, Deepak L. Bhatt, Andrew T. Yan, Bernard Zinman, Lawrence A. Leiter, David A. Hess, Hwee Teoh, Sandra Sabongui, Mohammed Al-Omran, Adrian Quan, Kim A. Connelly, C. David Mazer, Natasha Dhingra, Daniella C. Terenzi, Subodh Verma
Publikováno v:
Cell metabolism. 30(4)
Hess et al. quantified circulating aldehyde dehydrogenase-expressing (ALDHhi) cell subsets in people with T2DM given either empagliflozin (EMPA) or placebo. EMPA treatment increased circulating pro-angiogenic CD133+ progenitor cells, decreased pro-in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f62ae5efc404191a80ff514cf3b3dbc4
https://pubmed.ncbi.nlm.nih.gov/32302528
https://pubmed.ncbi.nlm.nih.gov/32302528